Furusawa, K.; Iino, C.; Mikami, K.; Sato, S.; Yoshida, K.; Nakaji, S.; Mikami, T.; Sakuraba, H.
Alcohol Intake, Cardiometabolic Risk, Fibrosis, and Gut Microbiota in Steatotic Liver Disease: A Population-Based Health Checkup Study. J. Clin. Med. 2026, 15, 2860.
https://doi.org/10.3390/jcm15082860
AMA Style
Furusawa K, Iino C, Mikami K, Sato S, Yoshida K, Nakaji S, Mikami T, Sakuraba H.
Alcohol Intake, Cardiometabolic Risk, Fibrosis, and Gut Microbiota in Steatotic Liver Disease: A Population-Based Health Checkup Study. Journal of Clinical Medicine. 2026; 15(8):2860.
https://doi.org/10.3390/jcm15082860
Chicago/Turabian Style
Furusawa, Keisuke, Chikara Iino, Keita Mikami, Satoshi Sato, Kenta Yoshida, Shigeyuki Nakaji, Tatsuya Mikami, and Hirotake Sakuraba.
2026. "Alcohol Intake, Cardiometabolic Risk, Fibrosis, and Gut Microbiota in Steatotic Liver Disease: A Population-Based Health Checkup Study" Journal of Clinical Medicine 15, no. 8: 2860.
https://doi.org/10.3390/jcm15082860
APA Style
Furusawa, K., Iino, C., Mikami, K., Sato, S., Yoshida, K., Nakaji, S., Mikami, T., & Sakuraba, H.
(2026). Alcohol Intake, Cardiometabolic Risk, Fibrosis, and Gut Microbiota in Steatotic Liver Disease: A Population-Based Health Checkup Study. Journal of Clinical Medicine, 15(8), 2860.
https://doi.org/10.3390/jcm15082860
